Rossari Biotech Limited (ROSSARI.NS)
INR 803.9
(-1.06%)
INR 803.9
(-1.06%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 18.3 Billion | 16.55 Billion | 14.75 Billion | 7.07 Billion | 5.98 Billion | 5.13 Billion |
| Cost of Revenue | 13.04 Billion | 11.71 Billion | 11.1 Billion | 4.78 Billion | 3.81 Billion | 3.47 Billion |
| Gross Profit | 5.26 Billion | 4.84 Billion | 3.64 Billion | 2.28 Billion | 2.17 Billion | 1.65 Billion |
| Operating Expenses | 1.84 Billion | 3.24 Billion | 2.34 Billion | 1.28 Billion | 1.29 Billion | 999.2 Million |
| Selling, General and Administrative Expenses | 813.29 Million | 1.02 Billion | 662.37 Million | 392.95 Million | 465.03 Million | 377.35 Million |
| Research and Development Expenses | 70.17 Million | 82.55 Million | 59.53 Million | 75.01 Million | 53.53 Million | 38.62 Million |
| Other Expenses | 74.46 Million | 54.84 Million | 58.17 Million | 17 Million | 700 Thousand | 590 Thousand |
| Cost and Expenses | 14.17 Billion | 14.95 Billion | 13.45 Billion | 6.07 Billion | 5.1 Billion | 4.47 Billion |
| Operating Income | 4.12 Billion | 1.51 Billion | 1.29 Billion | 1 Billion | 879.63 Million | 656.37 Million |
| Interest Expense | 193.72 Million | 223.15 Million | 126.56 Million | 29.92 Million | 35.57 Million | 28.78 Million |
| Income Tax Expense | 469.26 Million | 369.62 Million | 385.8 Million | 267.92 Million | 225.88 Million | 177.09 Million |
| Earnings before Tax | 1.77 Billion | 1.44 Billion | 1.36 Billion | 1.06 Billion | 878.41 Million | 633.92 Million |
| Net Income | 1.3 Billion | 1.07 Billion | 976.74 Million | 802.2 Million | 652.53 Million | 456.83 Million |
| Earnings Per Share Basic | 23.67 | 19.46 | 17.81 | 15.58 | 13.42 | 9.44 |
| Earnings Per Share Diluted | 23.62 | 19.38 | 17.70 | 15.49 | 13.23 | 9.44 |
| Weighted Average Shares Outstanding | 55.2 Million | 55.11 Million | 54.84 Million | 51.56 Million | 48.61 Million | 48.4 Million |
| Weighted Average Shares Outstanding (Diluted) | 55.32 Million | 55.35 Million | 55.17 Million | 51.87 Million | 49.32 Million | 48.4 Million |
| Gross Margin | 0.29 | 0.29 | 0.25 | 0.32 | 0.36 | 0.32 |
| EBIT Margin | 0.14 | 0.14 | 0.13 | 0.18 | 0.18 | 0.15 |
| Profit Margin | 0.07 | 0.06 | 0.07 | 0.11 | 0.11 | 0.09 |
| EBITDA | 2.57 Billion | 2.11 Billion | 1.93 Billion | 1.3 Billion | 1.08 Billion | 784.57 Million |
| Earnings Before Tax Margin | 0.23 | 0.09 | 0.09 | 0.14 | 0.15 | 0.13 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 4.98 Billion | 4.89 Billion | 4.72 Billion | 18.3 Billion | 4.63 Billion | 4.83 Billion |
| Cost of Revenue | 3.4 Billion | 3.84 Billion | 3.79 Billion | 14.57 Billion | 3.22 Billion | 3.42 Billion |
| Gross Profit | 1.57 Billion | 1.04 Billion | 933.27 Million | 3.73 Billion | 1.4 Billion | 1.4 Billion |
| Operating Expenses | 1.06 Billion | 552.79 Million | 458.08 Million | 1.84 Billion | 922.08 Million | 922.51 Million |
| Selling, General and Administrative Expenses | 591.44 Million | 552.79 Million | 458.08 Million | - | 510.8 Million | 496.1 Million |
| Research and Development Expenses | - | - | 70.17 Million | - | - | - |
| Other Expenses | 1.06 Billion | 9.48 Million | 3.9 Million | 74.46 Million | 35.02 Million | 13.64 Million |
| Cost and Expenses | 4.47 Billion | 4.4 Billion | 4.25 Billion | 16.41 Billion | 4.15 Billion | 4.35 Billion |
| Operating Income | 507.82 Million | 495.14 Million | 475.19 Million | 1.89 Billion | 521.04 Million | 498.37 Million |
| Interest Expense | 36.81 Million | 36.85 Million | 37.04 Million | 193.72 Million | 43.23 Million | 50.29 Million |
| Income Tax Expense | 127.77 Million | 120.88 Million | 114.37 Million | 469.26 Million | 133.91 Million | 118.6 Million |
| Earnings before Tax | 481.1 Million | 467.77 Million | 453.85 Million | 1.77 Billion | 477.81 Million | 448.08 Million |
| Net Income | 353.33 Million | 348.99 Million | 341.32 Million | 1.3 Billion | 343.9 Million | 329.48 Million |
| Earnings Per Share Basic | 6.39 | 6.32 | 6.18 | - | 6.23 | 5.97 |
| Earnings Per Share Diluted | 6.38 | 6.32 | 6.17 | - | 6.21 | 5.95 |
| Weighted Average Shares Outstanding | 55.29 Million | 55.24 Million | 55.31 Million | 55.32 Million | 55.23 Million | 55.18 Million |
| Weighted Average Shares Outstanding (Diluted) | 55.38 Million | 55.24 Million | 55.31 Million | 55.32 Million | 55.37 Million | 55.37 Million |
| Gross Margin | 0.32 | 0.21 | 0.20 | 0.20 | 0.30 | 0.29 |
| EBIT Margin | 0.13 | 0.13 | 0.13 | - | 0.14 | 0.13 |
| Profit Margin | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 |
| EBITDA | 669.53 Million | 648.86 Million | 635.93 Million | - | 671.92 Million | 649.51 Million |
| Earnings Before Tax Margin | 0.10 | 0.10 | 0.10 | 0.10 | 0.11 | 0.10 |
6483
1846
HLGN
3319
300775
3710